Você procurou por: atazanavirja (Esloveno - Inglês)

atazanavirja.
atazanavir.

atazanavirja in
atazanavir and

koncentracije atazanavirja.
concentrations of these antiarrhythmics may be increased when co-administered with reyataz/ ritonavir.

auc atazanavirja ↓ 68
atazanavir auc ↓ 68%

kombinacijo atazanavirja in
prezista co-administered with

auc in cmin atazanavirja.
and cmin of atazanavir.

atazanavirja/ritonavirja ne
with atazanavir/ritonavir is not

atazanavirja lahko negativno
atazanavir cmin might negatively

atazanavirja, pričakujemo pa tudi
concentrations and is expected to

drugimi odmerki atazanavirja ni
co-administration with other doses

atazanavirja ni kliničnih podatkov.
no clinical data available for the

atazanavirja in/ali kobicistata v
these antiepileptics are expected to decrease atazanavir and/or cobicistat plasma concentrations.

auc atazanavirja/ r ↓ 0, 58 (0, 48 -
atazanavir/ r auc ↓ 0.58 (0.48-0.71) atazanavir/ r cmin ↓ 0.28 (0.20-0.40) atazanavir/ r cmax ↓ 0.72 (0.60-0.86)

atazanavirja (v obliki sulfata).
the

auc atazanavirja/r  0,58 (0,48
atazanavir/r 300/100mg: atazanavir/r auc  0.58 (0.48-0.71)

vpliv kobicistata na farmakokinetiko atazanavirja
effect of cobicistat on atazanavir pharmacokinetics

absorpcija atazanavirja je odvisna od ph.
the absorption of atazanavir is ph-dependent.

cmax atazanavirja/r  1,02 (0,85
atazanavir/r cmax  1.02 (0.85–

farmakokinetika atazanavirja izkazuje nelinearno razporeditev.
the pharmacokinetics of atazanavir exhibit a non-linear disposition.

cmin atazanavirja/r ↓ 0,28 (0,20-0,40)
atazanavir/r cmin ↓ 0.28 (0.20-0.40)